Torrent Pharma fined Rs 41 crore over alleged wrong GST refund

Durgmaker Torrent Pharmaceuticals, on Friday, informed the stock exchanges that it has been fined Rs 41 crores by a Joint Commissioner with the Central GST, Ahmedabad South Commission rate, alleging wrongful refund claims on export of goods.

According to a regulatory filing, the action was taken under Section 74 of the Central Goods and Services Tax Act, 2017, which deals with cases involving tax not paid, short-paid or erroneously refunded.

The department has alleged that the company received an erroneous GST refund on exports, prompting the penalty.

The company said it will file an appeal against the order and expressed confidence in securing relief. It added that it does not expect any material financial impact from the penalty “based on the company’s assessment.”

Operations and other activities are expected to continue without disruption while the appeal process is underway, the filing said.

Related Posts

Six Women Develop Serious Complications After C-Section

Jaipur/Kota — In a serious medical incident that has raised concerns over patient safety at government facilities, six women who underwent caesarean section deliveries at Kota’s New Medical College Hospital developed…

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Jaipur:  Continuing its statewide anti-adulteration and food safety enforcement drive, the Food Safety Department Rajasthan conducted a major inspection and sampling operation at a pharma biological manufacturing unit located in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Six Women Develop Serious Complications After C-Section

Six Women Develop Serious Complications After C-Section

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

Indian Pharma Majors Plan to Invest in US

Indian Pharma Majors Plan to Invest in US

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental